BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12203124)

  • 1. The Brn-3a transcription factor inhibits the pro-apoptotic effect of p53 and enhances cell cycle arrest by differentially regulating the activity of the p53 target genes encoding Bax and p21(CIP1/Waf1).
    Budram-Mahadeo V; Morris PJ; Latchman DS
    Oncogene; 2002 Sep; 21(39):6123-31. PubMed ID: 12203124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct promoter elements mediate the co-operative effect of Brn-3a and p53 on the p21 promoter and their antagonism on the Bax promoter.
    Perez-Sanchez C; Budhram-Mahadeo VS; Latchman DS
    Nucleic Acids Res; 2002 Nov; 30(22):4872-80. PubMed ID: 12433990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A minimal Bcl-x promoter is activated by Brn-3a and repressed by p53.
    Sugars KL; Budhram-Mahadeo V; Packham G; Latchman DS
    Nucleic Acids Res; 2001 Nov; 29(22):4530-40. PubMed ID: 11713302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function.
    Kong XT; Gao H; Stanbridge EJ
    J Biol Chem; 2001 Aug; 276(35):32990-3000. PubMed ID: 11395510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brn-3a transcription factor blocks p53-mediated activation of proapoptotic target genes Noxa and Bax in vitro and in vivo to determine cell fate.
    Hudson CD; Morris PJ; Latchman DS; Budhram-Mahadeo VS
    J Biol Chem; 2005 Mar; 280(12):11851-8. PubMed ID: 15598651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brn-3a/POU4F1 interacts with and differentially affects p73-mediated transcription.
    Hudson CD; Sayan AE; Melino G; Knight RA; Latchman DS; Budhram-Mahadeo V
    Cell Death Differ; 2008 Aug; 15(8):1266-78. PubMed ID: 18421303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-alpha induced p21(WAF1) but not Bax in colon cancer cells WiDr with mutated p53: important role of protein stabilization.
    Kobayashi N; Takada Y; Hachiya M; Ando K; Nakajima N; Akashi M
    Cytokine; 2000 Dec; 12(12):1745-54. PubMed ID: 11097743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Brn-3a POU family transcription factor stimulates p53 gene expression in human and mouse tumour cells.
    Budhram-Mahadeo V; Morris P; Ndisang D; Irshad S; Lozano G; Pedley B; Latchman DS
    Neurosci Lett; 2002 Dec; 334(1):1-4. PubMed ID: 12431761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brn-3b enhances the pro-apoptotic effects of p53 but not its induction of cell cycle arrest by cooperating in trans-activation of bax expression.
    Budhram-Mahadeo VS; Bowen S; Lee S; Perez-Sanchez C; Ensor E; Morris PJ; Latchman DS
    Nucleic Acids Res; 2006; 34(22):6640-52. PubMed ID: 17145718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor.
    Budhram-Mahadeo V; Morris PJ; Smith MD; Midgley CA; Boxer LM; Latchman DS
    J Biol Chem; 1999 May; 274(21):15237-44. PubMed ID: 10329733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation during p21WAF1/CIP1-induced apoptosis in human ovarian cancer cells.
    Wu Q; Kirschmeier P; Hockenberry T; Yang TY; Brassard DL; Wang L; McClanahan T; Black S; Rizzi G; Musco ML; Mirza A; Liu S
    J Biol Chem; 2002 Sep; 277(39):36329-37. PubMed ID: 12138103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas.
    Bukholm IK; Nesland JM
    Virchows Arch; 2000 Mar; 436(3):224-8. PubMed ID: 10782880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression of POU4F2/Brn-3b with p53 may be important for controlling expression of pro-apoptotic genes in cardiomyocytes following ischaemic/hypoxic insults.
    Budhram-Mahadeo V; Fujita R; Bitsi S; Sicard P; Heads R
    Cell Death Dis; 2014 Oct; 5(10):e1503. PubMed ID: 25356872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of Brn-3a on neuronal differentiation and apoptosis are differentially modulated by EWS and its oncogenic derivative EWS/Fli-1.
    Gascoyne DM; Thomas GR; Latchman DS
    Oncogene; 2004 May; 23(21):3830-40. PubMed ID: 15021903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of p21WAF1 sensitizes cells to apoptosis via an increase of both p14ARF and p53 levels and an alteration of the Bax/Bcl-2 ratio.
    Javelaud D; Besancon F
    J Biol Chem; 2002 Oct; 277(40):37949-54. PubMed ID: 12151395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function.
    Ludwig RL; Bates S; Vousden KH
    Mol Cell Biol; 1996 Sep; 16(9):4952-60. PubMed ID: 8756654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis or senescence-like growth arrest: influence of cell-cycle position, p53, p21 and bax in H2O2 response of normal human fibroblasts.
    Chen QM; Liu J; Merrett JB
    Biochem J; 2000 Apr; 347(Pt 2):543-51. PubMed ID: 10749685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J; Le HV; Massagué J
    Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1.
    Zacharatos PV; Gorgoulis VG; Kotsinas A; Manolis EN; Liloglou T; Rassidakis AN; Kanavaros P; Field JD; Halazonetis T; Kittas C
    Anticancer Res; 1999; 19(1A):579-87. PubMed ID: 10226602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
    Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
    Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.